Blood and Bone Marrow Transplantation
The bone marrow transplantation program at the Lombardi Comprehensive Cancer Center is committed to both clinical and laboratory research.
The clinical realm involves allogeneic transplantation using matched related donors, unrelated donors and cord blood transplantations. One particularly active area of research is in high-risk breast cancer patients. We have been evaluating the use of immune therapy following high dose chemotherapy and stem cell infusions since 1994.
In the laboratory, the researchers and physicians are evaluating ways to stimulate a patient's immune system after transplantation using the patient's own cells. This type of therapy has extended to treatment of breast cancer and hematologic malignancies, including the lymphomas. We are also working in collaboration with other institutions evaluating new therapies for multiple myeloma.